Management of corticosteroid-induced osteoporosis
- 1 February 2000
- journal article
- review article
- Published by Elsevier BV in Seminars in Arthritis and Rheumatism
- Vol. 29 (4), 228-251
- https://doi.org/10.1016/s0049-0172(00)80011-6
Abstract
No abstract availableKeywords
This publication has 100 references indexed in Scilit:
- Cyclical etidronate in the prevention of bone loss in corticosteroid-treated primary biliary cirrhosis: A prospective, controlled pilot studyJournal of Hepatology, 1997
- The heritability of bone mineral density, ultrasound of the calcaneus and hip axis length: A study of postmenopausal twinsJournal of Bone and Mineral Research, 1996
- Oral alendronate induces progressive increases in bone mass of the spine, hip, and total body over 3 years in postmenopausal women with osteoporosisBone, 1996
- A randomized, double-masked, placebo-controlled trial of chlorthalidone and bone loss in elderly womenOsteoporosis International, 1995
- Glucocorticoids decrease vitamin D receptor number and gene expression in human osteosarcoma cellsJournal of Bone and Mineral Research, 1992
- Effect of Intermittent Cyclical Etidronate Therapy on Bone Mass and Fracture Rate in Women with Postmenopausal OsteoporosisNew England Journal of Medicine, 1990
- Glucocorticoid-Induced OsteoporosisNew England Journal of Medicine, 1983
- Steroid-Induced Fractures and Bone Loss in Patients with AsthmaNew England Journal of Medicine, 1983
- The intestinal handling of calcium by the rat in vivo, as affected by cortisol. Effect of dietary calcium supplementsCalcified Tissue International, 1978
- Corticosteroid and boneJournal of Anatomy, 1970